美国上诉法院周五表示，不会重新审理一项裁决，该裁决使数百起针对泰诺生产商肯维公司的诉讼得以恢复，这些诉讼称该受欢迎的止痛药可能导致自闭症。
戴安娜·诺瓦克·琼斯 报道 在一份简短的命令中，曼哈顿第二美国巡回上诉法院表示，正在拒绝该公司的请求，该公司是从强生公司分拆出来的，要求重新审理由三人小组作出的裁决，或让全院审理此案。
七月份，该小组恢复了大约500起由父母提起的诉讼，这些诉讼声称孕妇使用泰诺与儿童患自闭症和注意力缺陷多动障碍（ADHD）有关。
A US appeals court said on Friday it won’t reconsider a ruling reviving hundreds of lawsuits against Tylenol maker Kenvue alleging the popular painkiller can cause autism.
在这项裁决中，法院表示，地方法院法官不当地排除了三位医生的专家证词，这些证词支持父母的主张。
肯维公司要求法院重新考虑该决定，称地方法院法官是“真正的守门人”，他们决定证据是否可靠到足以在审判中被采纳。肯维公司发言人未能立即回应置评请求。周五的裁决可能为该公司向美国最高法院上诉铺平道路。
By Diana Novak Jones In a brief order, the 2nd US Circuit Court of Appeals in Manhattan said it was rejecting a request from the company, which was spun off from Johnson & Johnson, to reconsider the three-judge panel’s ruling or to have the full court hear the case In July, the panel revived about 500 lawsuits filed by parents over claims Tylenol use during pregnancy is linked to autism and attention deficit hyperactivity disorder (ADHD) in children In that ruling, the court said a district court judge improperly excluded expert testimony from three doctors supporting the parents’ claims Kenvue asked the court to reconsider the decision, saying district judges are the "true gatekeepers" who decide whether evidence is reliable enough to be admitted at trial A spokesperson for Kenvue did not immediately respond to a request for comment Friday’s ruling could pave the way for the company to appeal to the US Supreme Court